Literature DB >> 29221281

Is compensatory hyperhidrosis after thoracic sympathicotomy in palmar hyperhidrosis patients related to the excitability of thoracic sympathetic ganglions?

Jun-Peng Chen1, Rui-Fu Chen1, A-Jing Peng1, Chen-Hui Xu1, Guo-Ying Li1.   

Abstract

BACKGROUND: The mechanism of compensatory hyperhidrosis remains unclear. The aim of this study was to explore the relationship between compensatory hyperhidrosis and thoracic sympathetic ganglion excitability to assess the effectiveness of thoracoscopic T4 sympathicotomy for treating palmar hyperhidrosis.
METHODS: Sixty-six cases of T4 sympathetic ganglions were prospectively collected from patients with palmar hyperhidrosis who underwent thoracoscopic T4 sympathicotomy from 2013 to 2016 in our department. The expression levels of choline acetyltransferase (ChAT), vasoactive intestinal peptide (VIP), and synaptophysin were detected using immunohistochemistry. Patients with palmar hyperhidrosis were followed-up for examination of postoperative sweating status.
RESULTS: Thirty-eight cases (57.6%) of compensatory hyperhidrosis were identified. Mild compensatory hyperhidrosis occurred in 26 patients (39.4%), moderate in 11 (16.7%), and severe in 1 (1.5%). The rate of compensatory hyperhidrosis was higher in patients with axilla hyperhidrosis than those without (76.0% vs. 46.3%, P=0.018). However, the clinical data were similar between the compensatory hyperhidrosis group and the no compensatory hyperhidrosis group. In addition, the ChAT, VIP, and synaptophysin expression levels were not significantly different between the two groups (P values of 0.356, 0.071, and 0.141, respectively). Furthermore, the ChAT, VIP, and synaptophysin expression levels in the mild group were similar to those observed in the moderate/intense group (P values of 0.089, 0.124, and 0.149, respectively). The remission rate was 100% in palmar hyperhidrosis, 48.2% (27/56) in pedal hyperhidrosis, 56.0% (14/25) in axilla hyperhidrosis and 88.9% (16/18) in skin symptoms. No signs of chapped skin on the palms were found.
CONCLUSIONS: There was no significant correlation between compensatory hyperhidrosis and thoracic sympathetic ganglion excitability; however, compensatory hyperhidrosis is more likely to simultaneously occur in patients with axilla hyperhidrosis. The satisfactory efficacy of thoracoscopic T4 sympathicotomy indicates that it may an ideal technique for palmar hyperhidrosis.

Entities:  

Keywords:  Hyperhidrosis; compensatory; excitability; sympathicotomy

Year:  2017        PMID: 29221281      PMCID: PMC5708485          DOI: 10.21037/jtd.2017.08.100

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  21 in total

1.  Treatment of palmar hyperhidrosis by endoscopic clipping of the upper part of the T4 sympathetic ganglion. Preliminary results.

Authors:  Bong Chun Choi; Young Chul Lee; Sung Bo Sim
Journal:  Clin Auton Res       Date:  2003-12       Impact factor: 4.435

2.  Endoscopic thoracic sympathectomy for palmar hyperhidrosis: a randomized control trial comparing T3 and T2-4 ablation.

Authors:  Xu Li; Yuan-Rong Tu; Min Lin; Fan-Cai Lai; Jian-Feng Chen; Zhu-Jian Dai
Journal:  Ann Thorac Surg       Date:  2008-05       Impact factor: 4.330

Review 3.  Video-assisted thoracoscopic sympathectomy for palmar hyperhidrosis: results in 102 cases.

Authors:  Pierre Alric; Pascal Branchereau; Jean-Philippe Berthet; Philippe Léger; Henri Mary; Charles Mary-Ané
Journal:  Ann Vasc Surg       Date:  2002-11-07       Impact factor: 1.466

4.  Hippocampal neuron and synaptophysin-positive bouton number in aging C57BL/6 mice.

Authors:  M E Calhoun; D Kurth; A L Phinney; J M Long; J Hengemihle; P R Mouton; D K Ingram; M Jucker
Journal:  Neurobiol Aging       Date:  1998 Nov-Dec       Impact factor: 4.673

5.  Calcium-dependent transmitter secretion reconstituted in Xenopus oocytes: requirement for synaptophysin.

Authors:  J Alder; B Lu; F Valtorta; P Greengard; M M Poo
Journal:  Science       Date:  1992-07-31       Impact factor: 47.728

6.  Increase in nerve growth factor-like immunoreactivity and decrease in choline acetyltransferase following contusive spinal cord injury.

Authors:  C Bakhit; M Armanini; W L Wong; G L Bennett; J R Wrathall
Journal:  Brain Res       Date:  1991-07-19       Impact factor: 3.252

7.  Severity of compensatory sweating after thoracoscopic sympathectomy.

Authors:  Peter B Licht; Hans K Pilegaard
Journal:  Ann Thorac Surg       Date:  2004-08       Impact factor: 4.330

8.  Vasoactive intestinal polypeptide facilitates muscarinic transmission in mammalian sympathetic ganglia.

Authors:  N Mo; N J Dun
Journal:  Neurosci Lett       Date:  1984-11-23       Impact factor: 3.046

Review 9.  Hyperhidrosis: a review of current management.

Authors:  Joanne L Atkins; Peter E M Butler
Journal:  Plast Reconstr Surg       Date:  2002-07       Impact factor: 4.730

10.  Surgical treatment of primary palmar hyperhidrosis: a prospective randomized study comparing T3 and T4 sympathicotomy.

Authors:  Yanguo Liu; Jie Yang; Jun Liu; Fan Yang; Guanchao Jiang; Jianfeng Li; Yuqing Huang; Jun Wang
Journal:  Eur J Cardiothorac Surg       Date:  2009-01-21       Impact factor: 4.191

View more
  3 in total

1.  New sympathicotomy for prevention of severe compensatory hyperhidrosis in patients with primary hyperhidrosis.

Authors:  Jung Wook Han; Jae Jun Kim; Yong Hwan Kim; In Sub Kim; Seong Cheol Jeong
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 2.895

2.  Heart rate variability as a potential diagnostic tool to predict compensatory hyperhidrosis after sympathectomy in patients with primary focal hyperhidrosis.

Authors:  Seong Cheol Jeong; Jae Jun Kim; Yong Hwan Kim; In Sub Kim; Jung Wook Han; Seok Whan Moon
Journal:  J Thorac Dis       Date:  2020-11       Impact factor: 2.895

3.  Patient experience and prognostic factors of compensatory hyperhidrosis and recurrence after endoscopic thoracic sympathicotomy.

Authors:  Wongi Woo; Bong Jun Kim; Du-Young Kang; Jongeun Won; Duk Hwan Moon; Sungsoo Lee
Journal:  Surg Endosc       Date:  2022-05-09       Impact factor: 3.453

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.